0001478242-24-000057.txt : 20240304 0001478242-24-000057.hdr.sgml : 20240304 20240304172714 ACCESSION NUMBER: 0001478242-24-000057 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240229 FILED AS OF DATE: 20240304 DATE AS OF CHANGE: 20240304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STAUB W RICHARD CENTRAL INDEX KEY: 0001181162 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35907 FILM NUMBER: 24716182 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IQVIA HOLDINGS INC. CENTRAL INDEX KEY: 0001478242 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 271341991 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2400 ELLIS ROAD CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-998-2000 MAIL ADDRESS: STREET 1: 2400 ELLIS ROAD CITY: DURHAM STATE: NC ZIP: 27703 FORMER COMPANY: FORMER CONFORMED NAME: Quintiles IMS Holdings, Inc. DATE OF NAME CHANGE: 20161003 FORMER COMPANY: FORMER CONFORMED NAME: Quintiles Transnational Holdings Inc. DATE OF NAME CHANGE: 20091208 4 1 wk-form4_1709591202.xml FORM 4 X0508 4 2024-02-29 0 0001478242 IQVIA HOLDINGS INC. IQV 0001181162 STAUB W RICHARD C/O IQVIA HOLDINGS INC. 2400 ELLIS ROAD DURHAM NC 27703 0 1 0 0 See Remarks 0 Common Stock 2024-02-29 4 S 0 8970 247.33 D 21075 D Common Stock 2024-02-29 4 S 0 3062 248.33 D 18013 D Common Stock 2024-02-29 4 S 0 2068 249.08 D 15945 D The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $246.84 to $247.83 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $247.84 to $248.82, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $248.84 to $249.47, inclusive. President, Research & Development Solutions /s/ Matthew Gilmartin, Attorney-in-Fact for W. Richard Staub 2024-03-04